✕
Sunday, April 12, 2026
Breaking
New ‘Liquid Biopsy’ Blood Test Detects Heart Failure Risk Five Years Before Symptoms Develop·Liquid Biopsy Detects 12 Cancer Types From a Single Blood Draw With 89% Accuracy·Statin Use in Adults Over 75 Reduces Heart Attack Risk by 28%, Largest-Ever Meta-Analysis Confirms·New Blood Test Detects Parkinson’s Disease Up to 7 Years Before Symptoms Appear·Wearable ECG Patches Detect Atrial Fibrillation With 94% Accuracy in 30-Day Monitoring Study·New mRNA Vaccine Provides 94% Protection Against All Major Influenza A Subtypes in Phase 3 Trial·WHO Declares H5N1 Bird Flu a Public Health Emergency After Human-to-Human Transmission Confirmed in Three Countries·New ‘Liquid Biopsy’ Blood Test Detects Heart Failure Risk Five Years Before Symptoms Develop·Liquid Biopsy Detects 12 Cancer Types From a Single Blood Draw With 89% Accuracy·Statin Use in Adults Over 75 Reduces Heart Attack Risk by 28%, Largest-Ever Meta-Analysis Confirms·New Blood Test Detects Parkinson’s Disease Up to 7 Years Before Symptoms Appear·Wearable ECG Patches Detect Atrial Fibrillation With 94% Accuracy in 30-Day Monitoring Study·New mRNA Vaccine Provides 94% Protection Against All Major Influenza A Subtypes in Phase 3 Trial·WHO Declares H5N1 Bird Flu a Public Health Emergency After Human-to-Human Transmission Confirmed in Three Countries·
Tag

FDA Approval

FDA Approves Groundbreaking Alzheimer’s Drug That Slows Cognitive Decline by 47%Neurology

FDA Approves Groundbreaking Alzheimer’s Drug That Slows Cognitive Decline by 47%

Dr. Sarah ChenMar 12, 2026 · 3 min read
Breakthrough CRISPR Treatment Cures Hereditary Blindness in 90% of Patients in Phase 3 TrialResearch

Breakthrough CRISPR Treatment Cures Hereditary Blindness in 90% of Patients in Phase 3 Trial

James WhitfieldMar 11, 2026 · 2 min read
FDA Approves First Oral Treatment for Postpartum Depression — Works Within HoursPharmacology

FDA Approves First Oral Treatment for Postpartum Depression — Works Within Hours

Dr. Priya NairMar 7, 2026 · 2 min read
Gene Therapy Casgevy Produces Functional Cure in 93% of Sickle Cell Patients at 2-Year Follow-UpResearch

Gene Therapy Casgevy Produces Functional Cure in 93% of Sickle Cell Patients at 2-Year Follow-Up

Dr. Priya NairMar 6, 2026 · 2 min read
Pfizer’s RSV Vaccine Provides 89% Protection Against Severe Disease in Adults Over 60 at 3-Year Follow-UpInfectious Disease

Pfizer’s RSV Vaccine Provides 89% Protection Against Severe Disease in Adults Over 60 at 3-Year Follow-Up

James WhitfieldMar 5, 2026 · 2 min read
Pancreatic Cancer Survival Rates Double After New Combination Immunotherapy Approved by FDAOncology

Pancreatic Cancer Survival Rates Double After New Combination Immunotherapy Approved by FDA

James WhitfieldMar 3, 2026 · 2 min read
First Oral GLP-1 Drug Approved: Rybelsus Upgraded Formulation Shows Weight Loss Equivalent to Weekly InjectionsPharmacology

First Oral GLP-1 Drug Approved: Rybelsus Upgraded Formulation Shows Weight Loss Equivalent to Weekly Injections

Dr. Sarah ChenFeb 26, 2026 · 2 min read